Literature DB >> 16337795

Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling.

Jacqueline M Mason1, Debra J Morrison, M Albert Basson, Jonathan D Licht.   

Abstract

Receptor tyrosine kinases (RTKs) control a wide variety of processes in multicellular organisms, including proliferation, differentiation, migration and survival. Their activity is tightly controlled through the coordinated action of both positive and negative regulators that function at multiple levels of the signal transduction cascade, and at different time points within the growth-factor-induced response. When this process goes awry, the outcome can be developmental defects and malignancy. Sprouty (Spry) proteins represent a major class of ligand-inducible inhibitors of RTK-dependent signaling pathways. New biochemical and genetic evidence indicates specific roles of the Spry genes in development and multiple modes of action of the Spry proteins in regulation of the RTK-induced response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337795     DOI: 10.1016/j.tcb.2005.11.004

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  199 in total

1.  The many faces of RET dysfunction in kidney.

Authors:  Sanjay Jain
Journal:  Organogenesis       Date:  2009-10       Impact factor: 2.500

2.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

3.  Signaling by FGFR2b controls the regenerative capacity of adult mouse incisors.

Authors:  Sara Parsa; Koh-Ichi Kuremoto; Kerstin Seidel; Reza Tabatabai; Breanne Mackenzie; Takayoshi Yamaza; Kentaro Akiyama; Jonathan Branch; Chester J Koh; Denise Al Alam; Ophir D Klein; Saverio Bellusci
Journal:  Development       Date:  2010-11       Impact factor: 6.868

4.  Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Authors:  Meredith A Tennis; Michelle M Van Scoyk; Scott V Freeman; Katherine M Vandervest; Raphael A Nemenoff; Robert A Winn
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

Review 5.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

Review 6.  Comparative mechanisms of branching morphogenesis in diverse systems.

Authors:  Pengfei Lu; Mark D Sternlicht; Zena Werb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

7.  Branching morphogenesis.

Authors:  Arie Horowitz; Michael Simons
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

8.  Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer.

Authors:  Linda A Dultz; Shumon Dhar; Jennifer B Ogilvie; Keith S Heller; Dafna Bar-Sagi; Kepal N Patel
Journal:  Surgery       Date:  2013-10-02       Impact factor: 3.982

9.  Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.

Authors:  Matthew J Frank; David W Dawson; Steven J Bensinger; Jason S Hong; Wendy M Knosp; Lizhong Xu; Cynthia E Balatoni; Eric L Allen; Rhine R Shen; Dafna Bar-Sagi; Gail R Martin; Michael A Teitell
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

10.  Xenopus Paraxial Protocadherin regulates morphogenesis by antagonizing Sprouty.

Authors:  Yingqun Wang; Patricia Janicki; Isabelle Köster; Corinna D Berger; Christian Wenzl; Jörg Grosshans; Herbert Steinbeisser
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.